Medindia

X

Asymchem Announces Fall Process Symposium Confirmed List of Speakers

Thursday, September 17, 2009 General News J E 4
Advertisement


TEDA TIANJIN, China, Sept. 4 Asymchem Life Science (Tianjin) Co. Ltd., a wholly-owned subsidiary of Asymchem Laboratories Inc., a leading research-based contract manufacturer of API's and intermediates and Drug Products to the pharmaceutical industry, is pleased to issue the final confirmed list of speakers for the upcoming Fall Symposium in Process Chemistry held in Asymchem Life Science in TEDA Tianjin, P.R. China, from October 17-19, 2009.

Company and Academic speakers to present at Asymchem's Fall Process Chemistry Symposium Oct 17-19, 2009:

"We are pleased to bring together industrial and academic experts in the field of process chemistry and synthetic organic chemistry for a 3-day event," says Dr. Hao Hong, President and CEO of Asymchem. "The symposium will showcase new developments in the process field and provide a forum of discussion as to the state of the API contract R&D and manufacturing business in China, with a direct view into one of the key suppliers at the forefront."

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.

No. Company Speaker Title Topic --- ------- ------- ----- ----- 1 Merck Joe Armstong Senior Dir., Innovation as the Process Driver of Green Research Chemistry Advances in the Pharmaceutical Industry 2 Lilly Hannah Yu Scientist Development of an Efficient Palladium-Catalyzed Intramolecular Carbometalation Reaction for the Synthesis of a Dibenzoxapine Containing Tetrasubstituted Exocyclic Alkene 3 Pfizer Yousef Principal Evolution of the Hajikarimian Scientist manufacturing process to UK-369,003-26 / a PDE5 inhibitor for treatment of multiple indications 4 Pfizer Matt Birchmeier Physical Crystallization: properties Theory, Methods, and Scientist Analyses 5 Concert Andy Jones Senior Dir., The Challenge of Chemistry Large-scale Manufacture of Deuterated APIs 6 Lexicon Winston Wu Senior Dir., Process Chemistry in a Chemical Small Biotech Company: Development A Case Study 7 BMS Mauricio Futran VP, Process API and Intermediates R&D Outsourcing: The Changing Value Proposition for Suppliers 8 BMS Stephen VP, Pharmaceutical Analysis Scypinski Analytical in the 21st Century: R&D New Challenges and New Solutions 9 Lilly Scott Bradley Scientist NMR-based Reaction Monitoring: From Small Molecules to Biologics 10 Roche Yi Ren Head of Drug Process Research of a Supply and Glucose Kinase Discovery Activator for the Technology Treatment of Type-II Diabetes 11 University Richard Hsung Professor Total Synthesis of of Phomactin A. Wisconsin 12 University Andy Evans Professor New Asymmetric Methods of for Heterocyclic Liverpool Synthesis - Total Synthesis of Marinomycin A 13 North Muk Sibi Professor Chiral Lewis and Dakota Bronsted Acid State Catalysis: University Exploration of Asymmetric Transformations 14 Swiss Erick Carreira Professor Surprises and Federal Discoveries with Institute Natural Products of Technology 15 West George Asst De Novo Synthesis in Virginia O'Doherty Professor Carbohydrate Chemistry University 16 AstraZeneca Andy Wells 17 Beijing Xi Zhenfeng Professor University 18 Nankai Zhou Qilin Professor University 19 Tianjin Sun Yan Professor University 20 Lanzhou Wang Rui Professor University

SOURCE Asymchem Life Science (Tianjin) Co. Ltd.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
KV Pharmaceutical Appoints Interim Chief Financial...
S
/C O R R E C T I O N -- Fred Hutchinson Cancer Res...